Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > BUSINESS
BUSINESS
- Meiji Seika Pharma, Takeda to Copromote Insomnia Treatment Rozerem from October
September 8, 2014
- Bayer Yakuhin Files Eylea for Macular Edema Secondary to Branch Retinal Vein Occlusion
September 8, 2014
- Takeda Files Leuplin 6-Month Depot Formulation in Japan
September 8, 2014
- MSD’s Januvia Logs 1st Sales Decline in Japan on Re-Pricing
September 5, 2014
- Januvia Retains Its No. 1 Spot in the GP Market in July: Anterio’s “Mind Share” Ranking
September 5, 2014
- Takeda Transfers All Shares of Its Subsidiary Nippon-Rinshosha to Medical Tribune
September 5, 2014
- Sanofi Launches Prostate Cancer Agent Jevtana
September 5, 2014
- Kaketsuken Completes New Manufacturing Plant for Increasing Production Capacity of Hepatitis B Vaccine
September 5, 2014
- US Court Backs Jury Verdict in Actos Suit, Orders Takeda to Pay US$6 Billion in Punitive Damages
September 5, 2014
- TMRC to Collaborate with Children’s Hospital Los Angeles to Develop Treatment for Chemotherapy-Induced Neutropenia
September 4, 2014
- Bristol-Myers’ Dual Oral Hepatitis C Regimen Debuts in Japan
September 4, 2014
- Prostate Cancer Drug Zytiga Now Available in Japan: Janssen
September 4, 2014
- GSK’s 2013 Payments to Health Professionals in Japan at 10 Billion Yen
September 4, 2014
- Torii’s Sublingual Hay Fever Drug to Hit Market in October
September 4, 2014
- Ichiro Yoshimoto to Become New President of CMIC
September 4, 2014
- CMIC Holdings to Boost Domestic CSO Business, Converting Its Subsidiary to JV with UDG Healthcare
September 4, 2014
- Drug Price Settlement Rate Might Hit 70% in September: Wholesaler Exec
September 3, 2014
- Daiichi Sankyo Espha to Launch AG Versions of Cravit after NHI Price Listing in December
September 3, 2014
- Ono Launches Opdivo, Making Full-Fledged Entry to Oncology Field
September 3, 2014
- Eisai Books 18.7 Billion Yen in Payments to Medical Institutions in FY2013
September 2, 2014
ページ
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…